Public relations: GlaxoSmithKline assigns Hepsera to Awareness ID

HO CHI MINH CITY: GlaxoSmithKline has launched oral hepatitis B drug Hepsera onto the Vietnam market, tasking Awareness I.D. with the creation of an educational campaign to communicate the disease's high incidence (12 per cent) in the country.